Published in Hepatitis Weekly, November 28th, 2005
This study is one of the first conducted among this population, and will help researchers understand the response to hepatitis C treatment among the Latino community.
To recruit additional patients, Roche has increased the number of trial sites to 60 (up from 45) throughout the United States and Puerto Rico. When recruitment is complete, the study will enroll a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly